Controlled, extended-release, local delivery of medication at effective release rates over predetermined durations.
PolyPid Ltd. is a global clinical-stage biopharmaceutical company dedicated to the development, manufacturing, and commercialization of innovative, locally administered therapies. PolyPid Ltd. focuses on enhancing surgical outcomes through advanced pharmaceutical solutions.
At the heart of PolyPid Ltd.'s innovation is its proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology, a unique platform designed to provide controlled and continuous delivery of medications directly at the surgical site. This targeted approach allows surgeons to precisely manage localized medical conditions such as infection, pain, inflammation, and cancer, ultimately improving patient outcomes and reducing healthcare burdens.
Located at Ha'Sivim 18, Petah Tikva, IL, PolyPid Ltd. is committed to reducing surgical infection rates, including those caused by antibiotic-resistant bacteria. PolyPid Ltd.'s mission aligns with addressing some of the most pressing public health challenges. We invite the manager of PolyPid Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the pharmaceutical industry.
Other organizations in the same industry
This company is also known as